IGC · IGC Pharma, Inc. · Insider Trading

Reporting Person's child who does not share the Reporting Person's household.

Reporting Person's two children who do not share the Reporting Person's household.

Reporting Person's two children who do not share the Reporting Person's household.

Shares of common stock acquired directly from the Issuer in a private placement in exchange for cancellation of $553,062 of outstanding indebtedness owed by the Issuer to the Reporting Person. The shares were issued at $0.27 per share, are restricted securities within the meaning of Rule 144, and were issued in a transaction exempt from registration under Section 4(a)(2) of the Securities Act of 1933. The transaction was approved in advance by the disinterested directors and the Audit Committee, with the Reporting Person recused, for purposes of Rule 16b-3.

Shares of common stock acquired directly from the Issuer in a private placement in exchange for cancellation of $601,148 of outstanding indebtedness owed by the Issuer to the Reporting Person. The shares were issued at $0.27 per share, are restricted securities within the meaning of Rule 144, and were issued in a transaction exempt from registration under Section 4(a)(2) of the Securities Act of 1933. The transaction was approved in advance by the disinterested directors and the Audit Committee, with the Reporting Person recused, for purposes of Rule 16b-3.

On June 26, 2025, the Reporting Person's spouse was granted RSUs.

Each restricted stock unit represents a right to receive one share of IGC common stock.

On June 26, 2025, the Reporting Person's spouse was granted RSUs.

On March 13, 2024, the Reporting Person was granted Options subject to vesting equally over three years starting in March 2025. The exercise price is $0.26.

Each restricted stock unit represents a right to receive one share of IGC common stock.

On June 20, 2023, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 31, 2024.

Each restricted stock unit represents a right to receive one share of IGC common stock.

On June 20, 2023, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 31, 2024.

On June 20, 2023, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 31, 2024.

On March 13, 2024, the Reporting Person was granted RSUs subject to vesting equally over three years starting March 2025.

On March 13, 2024, the Reporting Person was granted options exercisable at $0.26, vesting over three years starting in March 2025.

On March 13, 2024, the Reporting Person was granted RSUs subject to vesting equally over three years starting March 2025.

Each restricted stock unit represents a right to receive one share of IGC common stock.

On March 13, 2024, the Reporting Person was granted RSUs subject to vesting equally over three years starting March 2025.

On June 20, 2023, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 31, 2024.

Each restricted stock unit represents a right to receive one share of IGC common stock.

On February 3, 2026, the Reporting Person's spouse was granted RSUs.

On June 20, 2023, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 2024.

Each restricted stock unit represents a right to receive one share of IGC common stock.

On March 13, 2024, the Reporting Person was granted RSUs subject to vesting equally over three years starting March 2025.

Each restricted stock unit represents a right to receive one share of IGC common stock.

On June 20, 2023, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 2024.

Each restricted stock unit represents a right to receive one share of IGC common stock.

On June 20, 2023, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 31, 2024.

On March 13, 2024, the Reporting Person was granted options exercisable at $0.26, vesting over three years starting in March 2025.

On June 20, 2023, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 2024.

On February 3, 2026, the Reporting Person's spouse was granted RSUs.

On June 20, 2023, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 31, 2024.

On February 3, 2026, the Reporting Person's spouse were granted RSUs subject to immediate vesting.

Each restricted stock unit represents a right to receive one share of IGC common stock.

On February 3, 2026, the Reporting Person's spouse were granted RSUs subject to vesting equally over two years starting on March 31, 2026.

Each restricted stock unit represents a right to receive one share of IGC common stock.

On February 3, 2026, the Reporting Person's spouse were granted RSUs subject to vesting on March 31, 2026.

On March 13, 2024, the Reporting Person was granted RSUs subject to vesting according to specific milestones set by the Company's Board of Directors. The RSUs vest when milestones are achieved.

Each restricted stock unit represents a right to receive one share of IGC common stock.

On March 13, 2024, the Reporting Person was granted RSUs subject to vesting according to specific milestones set by the Company's Board of Directors. The RSUs vest when milestones are achieved.

The Reporting Person was granted Options subject to vesting according to specific milestones set by the Company's Board of Directors. The Options vest upon achievement of milestones. The exercise price is $0.35.

The Reporting Person was granted 500,000 options exercisable at $0.35, equally vesting over the next three years starting in March 31st 2026.

The Reporting Person was granted 500,000 options exercisable at $0.35, equally vesting over the next three years starting in March 31st 2026.

The Reporting Person was granted Options subject to vesting according to specific milestones set by the Company's Board of Directors. The Options vest when milestones are achieved. The exercise price is $0.35.

The Reporting Person was granted 1,000,000 options exercisable at $0.35, equally vesting over the next three years starting March 31st, 2026.

Gift of shares of the Company's common stock to the reporting person's children who do not share the reporting person's household.

The Reporting Person was granted options exercisable at $0.35, vesting equally over the next three years starting on March 31, 2026.

The Reporting Person was granted 750,000 options exercisable at $0.35, equally vesting over the next three years starting on March 31st, 2026.

Gift of shares of the Company's common stock to the reporting person's children who do not share the reporting person's household.

Each restricted stock unit represents a right to receive one share of IGC common stock.

On May 25, 2022, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 31, 2023.

Each restricted stock unit represents a right to receive one share of IGC common stock.

On June 20, 2023, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 31, 2024.

On June 20, 2023, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 31, 2024.

On March 13, 2024, the Reporting Person was granted RSUs subject to vesting equally over three years starting March 2025.

Each restricted stock unit represents a right to receive one share of IGC common stock.

On June 20, 2023, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 31, 2024.

Each restricted stock unit represents a right to receive one share of IGC common stock.

On June 20, 2023, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 31, 2024.

On June 20, 2023, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 31, 2024.

Each restricted stock unit represents a right to receive one share of IGC common stock.

On May 25, 2022, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 31, 2023.

On June 20, 2023, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 31, 2024.

On May 25, 2022, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 31, 2023.

On June 20, 2023, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 31, 2024.